Breaking News
USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS
INDEGENE AND CONTIPI MEDICAL LTD FORGE PARTNERSHIP
EU AND ITALY NOT EXPORTING ASTRAZENECA VACCINE TO AUSTRALIA
MEDTECS AND ACO INTERNATIONAL TO START JOINT VENTURE
Skip to content
  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
Medgazette 24

Medgazette 24

Healthcare Latest news, Medical Technology Updated News

  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
  • Home
  • Judith Agudo

Tag: Judith Agudo

Unique Beta Cells Hold Potential For Improved Diabetes Care

February 25, 2020 Shreyas TannaHealthcare, News

Judith Agudo, PhD, assistant professor in the cancer immunology and virology department at the Dana-Farber Cancer Institute and department of immunology at Harvard Medical School has won American Diabetes Association’s Pathway to Stop Diabetes grants. Her new theory might hold…

Recent News

IBS AND THE ROYAL SOCIETY TO COOPERATE ON COVID-19

March 3, 2021

SANOFI TO PRODUCE JOHNSON & JOHNSON’S COVID-19 VACCINE IN FRANCE

March 2, 2021

HIKMA DONATES OVER 4 MILLION USD IN MEDICINES

March 1, 2021

USFDA APPROVES POTASSIUM CHLORIDE ER CAPSULES FROM GRANULES INDIA

February 26, 2021

ONWARD THERAPEUTICS AND BIOMUNEX PHARMACEUTICALS SIGN NEW AGREEMENT

February 25, 2021

FRANCE BEGINS DISTRIBUTING COVID VACCINE AMID UK VARIANT WARNING

February 24, 2021

UK HEALTHCARE KENTUCKY’S FIRST EXCELLENT SYSTEM FOR HIDDEN SCAR BREAST CANCER SURGERY

February 23, 2021

RAMONA SEQUEIRA MAY SOON BE CHAIRPERSON OF PHRMA BOARD

February 22, 2021

UK GOVERNMENT EXTENDS WOCKHARDT’S CONTRACT CREATING NEW JOBS

February 19, 2021

ARTIOS PHARMA ANNOUNCES FIRST CLINICAL STUDY REGARDING ADVANCED NEXT-GEN DDR

February 18, 2021

Categories

  • Healthcare
    • Healthcare IT
  • Medicine
  • News
  • Pharamaceuticals
  • Research
Medicine
March 16, 2021

USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS

HIGHLIGHTS USFDA has approved the expanded age indication of cell-based Quadrivalent influenza…

Medicine
March 10, 2021

GERMANY’S MERCK SIGNS AGREEMENT FOR HEAD AND NECK CANCER DRUG

HIGHLIGHTS Merck has signed an agreement with Debiopharm. This is a €…

  • About Us
  • Authors
  • Contact Us
Copyright © All rights reserved.
Powered by WordPress | Magazine Point by Axle Themes